Cancel
About Ian Page
Ian Page is the Chief Executive Officer of Dechra, known for his significant role in the company's strategic growth and extensive experience in mergers and acquisitions.
Known information
Ian Page joined NVS, the precursor to Dechra, at its inception in 1989 and ascended to the role of Managing Director in 1998. He became a member of the Board in 1997. Throughout his tenure, Page has been instrumental in shaping the Group’s growth strategy, leveraging his extensive experience in mergers and acquisitions (M&A) and strategic plan execution. His expertise is not confined to the UK; he has a broad range of business development experience on a global scale. His leadership has been pivotal in driving Dechra’s expansion and operational success.
About Dechra Pharmaceuticals
Dechra Pharmaceuticals specializes in developing, manufacturing, and marketing veterinary products, serving veterinarians across 88 countries with a workforce of 2,457 employees.
Report inaccurate information
